Houston, TX, United States of America

Ebrahim S Delpassand

USPTO Granted Patents = 3 


 

Average Co-Inventor Count = 4.3

ph-index = 1

Forward Citations = 2(Granted Patents)


Company Filing History:


Years Active: 2016-2023

Loading Chart...
Loading Chart...
Loading Chart...
3 patents (USPTO):Explore Patents

Title: Ebrahim S Delpassand: Innovator in Cancer Treatment

Introduction

Ebrahim S Delpassand is a notable inventor based in Houston, TX (US). He has made significant contributions to the field of cancer treatment, holding a total of 3 patents. His work focuses on innovative methods to target and eliminate cancer cells, particularly those that overexpress somatostatin receptors.

Latest Patents

One of his latest patents involves the treatment of cancer cells overexpressing somatostatin receptors using ocreotide derivatives chelated to radioisotopes. This cancer-targeting composition includes a radioisotope, a chelator, and a targeting moiety. The chelator features a nitrogen ring structure that includes a tetraazacyclododecane, a triazacyclononane, and/or a tetraazabicyclo [6.6.2] hexadecane derivative. The targeting moiety consists of a somatostatin receptor targeting peptide, which includes an octreotide derivative. This innovative approach allows for the targeted elimination of cancer cells.

Another significant patent by Delpassand provides compositions, methods of synthesis, and use of carbohydrate-targeted agents. This invention features D02S derivatives conjugated to monosaccharide ligands, which can be directly linked or linked through a chelator to a metal. The D02S derivatives are designed to enhance targeting efficiency, showcasing Delpassand's commitment to advancing cancer treatment methodologies.

Career Highlights

Ebrahim S Delpassand has worked with Radiomedix Inc., a company focused on developing innovative radiopharmaceuticals for cancer treatment. His expertise and contributions have been instrumental in the advancement of targeted cancer therapies.

Collaborations

Throughout his career, Delpassand has collaborated with notable professionals in the field, including Izabela Tworowska and Jennifer Sims-Mourtada. These collaborations have further enriched his research and development efforts.

Conclusion

Ebrahim S Delpassand is a pioneering inventor whose work in cancer treatment continues to make a significant impact. His innovative patents and collaborations reflect his dedication to improving therapeutic options for patients battling cancer.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…